Prevention & lipids

Sex-related variations in platelet reactivity in presence or absence of antiplatelet therapy

Eur Heart J Cardiovasc PharmacotherPublished analysis of a large dataset of patients undergoing light transmission aggregometry (LTA)

Authors' conclusion

Females exhibit heightened baseline ADP-dependent platelet reactivity and a diminished response to aspirin and clopidogrel monotherapy compared to males.

Study context

Population
Patients undergoing light transmission aggregometry, with or without antiplatelet therapy, and healthy volunteersincluded after study entry criteria, of 11,913 patients who underwent LTA
Participants
5,687 patients
Comparison
Within each group, results were analysed and compared between males and females
  • Healthy volunteers (HV)n = 428
  • Controls (CTR)n = 1,055
  • ASAn = 3,289
  • CLOPn = 430
  • Dual antiplatelet therapy (DAPT)n = 485
Outcome
Platelet reactivity in response to adenosine diphosphate (ADP), females vs males
Methodological detailsstandardized methodology, sequential LTA assessments, 2004–2022
  • Standardized methodology
  • Sequential LTA assessments, 2004–2022

Main finding

As reported in the abstract

  • No significant sex difference in the DAPT group
  • Females vs males: P = 0.004
  • Females vs males: P < 0.0001
  • Females vs males: P < 0.0001
  • Females vs males: P < 0.018

Further findings

OutcomeP value
Platelet reactivity in response to collagen, aspirin-treated patientsFemales vs males · increased with femalesP < 0.0001

Original publication

Sex-related variations in platelet reactivity in presence or absence of antiplatelet therapy. Eur Heart J Cardiovasc Pharmacother. Published 14 May 2025. doi:10.1093/ehjcvp/pvaf034

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.